Canadian Medical Hall of Fame

Join Canada in recognizing Heart Month

Learn more about Canada's heart heroes

The Canadian
Medical Hall of Fame

The world’s only national Hall of Fame dedicated to celebrating the accomplishments of medical heroes.

The Canadian Medical Hall of Fame contributes to a vibrant health care system by engaging Canada’s health leaders in educational programs that encourage youth to pursue careers in health sciences.

Learn more about us         Support us 

Dr. Bernstein returned to Canada in 1974 to join the faculty of the Ontario Cancer Institute. In 1985, he was appointed to the new Samuel Lunenfeld Research Institute at Mount Sinai Hospital in Toronto, was named associate director in 1988 and then director of research (1994‐2000).  He attracted outstanding scientists and expanded the institute’s reputation and impact. In 2000, Dr. Bernstein led the transformation of health research in Canada as the founding president of the Canadian Institutes of Health Research (CIHR), and oversaw a close to three-fold increase in Canada’s budget for health research, enabling researchers to investigate significant health issues facing Canadians. During his seven year term, CIHR refocused and energized Canada’s health research community. Dr. Bernstein then served as the executive director of the Global HIV Vaccine Enterprise in New York, an international alliance of researchers and funders charged with accelerating the search for an HIV vaccine.  Since 2012, he has served as President & CEO of the Canadian Institute for Advanced Research (CIFAR), where he is leading this important global institution in new directions as it brings together close to 400 of Canada’s and the world’s top researchers to address questions of global importance that face humanity.Dr. Bernstein has been honoured with numerous awards for his contributions to science, including and six honorary degrees, the 2008 Gairdner Wightman Award, the McLaughlin Medal from the Royal Society of Canada and the Robert L. Noble Award from the National Cancer Institute of Canada. He is a Senior Fellow of both Massey College (University of Toronto) and the Munk School of Global Affairs. In 2002, he was named an Officer of the Order of Canada.
2015 Inductee
Dr. Hall completed medical school at The University of Washington and was also awarded a master’s of science degree in genetics for coursework and research done with Arno Motulsky. After completing a postdoctoral fellowship in medical genetics, she trained in pediatrics at Johns Hopkins Hospital from 1969 to 1971, and then completed a fellowship in pediatric endocrinology.Dr. Hall moved to the University of British Columbia (UBC) in 1981 as a professor of medical genetics and was appointed head of paediatrics at UBC and BC Children's Hospital in 1990.  She worked with physicians to develop guidelines for care of common disorders, and with lay groups to explain genetic disease that helped parents choose among the available care options.Dr. Hall specialized in the genetic factors that affect lack of children’s growth, including the mechanism of neural tube defects, the genetics of short stature and the genetics of connective tissue disorders such as arthrogryposis, dwarfism, and monozygotic twins.  She helped to clarify medical understanding of how folic acid helps reduce birth defects, and identified a new cause of dwarfism.Dr. Hall was the first to define Amyoplasia (the most common form of arthrogryposis) and the book she co-edited called Arthrogryposis: A Text Atlas became the definitive publication on arthrogryposis (a condition where some or all joints have reduced range of motion). Her publication Human Malformations and Related Anomalies, co-edited with Roger E. Stevenson, has become the best known and most widely used work on human congenital anomalies. Another book, The Handbook of Physical Measurements (Hall, Allinson, Gripp, Stavotinek) allows for quantitative description of congenital anomalies. She has published more than 325 papers in the clinical field and described new genetic syndromes, including one that bears her name Pallister-Hall syndrome. A tireless advocate for the field, Dr. Hall has helped lay groups form and connect internationally to encourage research, and be advocates for their particular diseases. She also participated in founding the Council of Canadian Academies, Canadian Academy of Health Sciences and Genome Canada. Dr. Hall has been honoured with more than 50 awards including the Order of Canada and Fellowship in the Royal Society of Canada. 
2015 Inductee
Upon completion of his medical degree, Dr. Langer completed postgraduate surgical training in Toronto, Houston and Boston.  He joined the Toronto General Hospital as a staff surgeon in 1963 and was appointed head of the division of general surgery in 1972. During his 17 year tenure, this division evolved from a broad-based clinical and teaching service to one with focused interests in specialty areas, placing equal importance on clinical care, teaching and research.  In 1982 Dr. Langer was appointed the Col. R.S. McLaughlin Professor and Chair for the Department of Surgery, Faculty of Medicine at the University of Toronto. Revolutionary in its time, he established the Surgeon Scientist Program, which provides structured high quality research training for surgical residents interested in careers in academic medicine. This is now a widely recognized and emulated model for training academic surgeons in Canada and in other countries. As a result of this program, numerous surgeons who graduated from the University of Toronto with combined training in surgical specialties, as well as advanced research training, now occupy leadership positions in departments of surgery across Canada and elsewhere.  As a member of council and then president of the Royal College of Physicians and Surgeons of Canada, Dr. Langer was instrumental in the creation of the Royal College of Physicians and Surgeons of Canada Clinician Investigator Program and in the formation of the Canadian Patient Safety Institute.Dr. Langer was made an Officer of the Order of Canada in 2002.
2015 Inductee
Dr. McCrae was born in Guelph, Ontario and won a scholarship to the University of Toronto at 16. He did his residency at the Toronto General Hospital and worked for a short period at Johns Hopkins University with Dr. William Osler. He wrote poetry during this time, winning a Saturday Night short story competition in 1894. His poems were published in The Canadian Magazine, The Westminister and Massey's Magazine.  In 1899, he accepted a pathology fellowship at McGill University, but postponed this opportunity to join the second contingent of Canadian soldiers in the South African War. He served with the Royal Regiment of Canadian Artillery and demonstrated conspicuous bravery as an artillery officer.  Returning to Montreal in January 1901, Dr. McCrae went on to complete specialist training under Dr. Adami. He was one of the first Canadians to receive formal training in laboratory research, and invented new processes to aid his study of agglutination of several bacteria. He authored more than 30 papers with research that included almost 1,000 autopsies, held academic appointments at McGill University, taught at the University of Vermont Medical College and conducted a private medical practice. In the First World War, Lt. Col McCrae served as the chief medical officer of the No. 3 Canadian General Hospital (McGill). He was an inspirational leader who worked to exhaustion in this role for two and half years, tragically succumbing to pneumonia in January 1918. Prior to his death, his extraordinary medical contribution to the war effort was recognized by Britain when he became the first Canadian-appointed consultant physician to the British Army. 
2015 Inductee
In 1981, Dr. Montaner joined UBC and completed his postgraduate and residency training.  As a young internist, he treated some of the earliest cases of AIDS in Canada.Since 1998, he has been the director of the UBC/SPH-AIDS Research Program and the Immunodeficiency Clinic. Having learned the power of combination drug treatment for tuberculosis from his father, Dr. Luis Julio Gonzalez Montaner, he began exploring combination antiretroviral therapy regimens for his patients in 1990, eventually leading an international consortium of investigators to test a novel triple drug combination called ‘highly active antiretroviral therapy’ (HAART) to suppress the progression of HIV disease. In 1996, HAART became the new standard of care in HIV medicine in North America and Europe, and was eventually adopted by the World Health Organization (WHO) and UNAIDS as the global standard in 2000. With his team, he established the impact of HAART on decreasing HIV transmission in BC, pioneering the notion of Treatment as Prevention (TasP). Embraced by UNAIDS in 2010, TasP was fully incorporated in the WHO Consolidated ARV Guidelines in 2013.  In September 2014, his TasP-inspired 90-90-90 Target was formally endorsed by the UN Secretary General as the new global strategy to eliminate the HIV pandemic. This calls for 90% of HIV cases to be diagnosed, 90% of them to have access to HAART, and 90% of them to be virologically suppressed globally. Meeting the 90-90-90 Target by 2020 is expected to lead to a 90% decrease in AIDS mortality and HIV incidence globally by 2030, transforming the devastating HIV pandemic into a rare endemic condition.Dr. Montaner has also launched multiple initiatives to improve access to HAART among hard-to-reach populations. Of particular note was his role in the establishment and success of North America’s first legal, supervised injection site - InSite in Vancouver. His many honours include the Prix Galien, FNG Starr Award of the CMA, Rx&D Health Research Foundation Medal of Honour and Albert Einstein World of Science Award. He is an officer of the Order of Canada, and a member of the Order of British Columbia, the Order of Austria and the Royal Society of Canada.
2015 Inductee
Dr. Sinclair graduated from the University of Toronto, Ontario Veterinary College (DVM and VS) in 1958, where continued studies led to a masters of science in agriculture in 1960. Dr. Sinclair completed a PhD in physiology at Queen's University in 1963, followed by a Meres Senior Scholarship in Medical Research at St. John’s College, Cambridge University from 1963 – 1965. He then joined the faculty at Queen’s University in 1966 as a Markle Scholar in Academic Medicine.After serving as Dean of Arts and Science from 1974 - 1983, Dr. Sinclair was then appointed to three vice principalships ‐ institutional relations, services, and health sciences. The latter appointment included a second deanship leading the faculty of medicine. As dean he redefined regional health care education, expanding and strengthening ties with partner hospitals.  In 1989, he received an Honorary Fellowship in the Royal College of Physicians and Surgeons of Canada in recognition of his contributions to medical scholarship and education. Dr. Sinclair’s astute and pragmatic leadership was called upon in health care reform. He led the governance subcommittee of the Steering Committee for Review of the Public Hospitals Act in Ontario and achieved national recognition as a member of the National Forum on Health. As chair of the Health Services Restructuring Commission (HSRC) of Ontario (1996‐2000), his rational, courageous and diplomatic leadership led to a re‐defined health system in Ontario. This restructuring of hospitals and new alignment of health care institutions was necessary, but the environment was challenging. Planning principles and recommendations based upon the HSRC blueprint remain contemporary, with recent commissions echoing the call for similar implementation. Dr. Sinclair was founding chair and acting CEO of Canada Health Infoway/Inforoute Santé du Canada, an organization designed to foster the development of a national capacity for health information management. He continues contributions to scholarship, teaching and policy development as a Fellow of the School of Policy Studies of Queen’s University.
2015 Inductee